These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9619689)

  • 1. Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats.
    Lagos P; Scorza C; Monti JM; Jantos H; Reyes-Parada M; Silveira R; Ponzoni A
    Eur Neuropsychopharmacol; 1998 May; 8(2):113-20. PubMed ID: 9619689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.
    Siuciak JA; Fujiwara RA
    Psychopharmacology (Berl); 2004 Sep; 175(2):163-9. PubMed ID: 14985923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors.
    Piercey MF; Hyslop DK; Hoffmann WE
    Brain Res; 1997 Jul; 762(1-2):19-28. PubMed ID: 9262154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locomotor hypoactivity and motor disturbances--behavioral effects induced by intracerebellar microinjections of dopaminergic DA-D2/D3 receptor agonists.
    Kolasiewicz W; Maj J
    Pol J Pharmacol; 2001; 53(5):509-15. PubMed ID: 11990070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Food restriction alters N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: evidence for sensitization of dopamine D2 receptor-mediated effects.
    Collins GT; Calinski DM; Newman AH; Grundt P; Woods JH
    J Pharmacol Exp Ther; 2008 May; 325(2):691-7. PubMed ID: 18305018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: a D3 receptor mediated effect?
    Boulay D; Depoortere R; Perrault G; Sanger DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Jan; 24(1):39-49. PubMed ID: 10659982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural evidence that different neurochemical mechanisms underly stretching-yawning and penile erection induced in male rats by SND 919, a new selective D2 dopamine receptor agonist.
    Ferrari F; Pelloni F; Giuliani D
    Psychopharmacology (Berl); 1993; 113(2):172-6. PubMed ID: 7855178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors.
    Svensson K; Carlsson A; Huff RM; Kling-Petersen T; Waters N
    Eur J Pharmacol; 1994 Oct; 263(3):235-43. PubMed ID: 7843260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of striatal acetylcholine on dopamine D1 receptor agonist-induced turning behavior in 6-hydroxydopamine lesioned rats: a microdialysis-behavioral study.
    Fenu S; Acquas E; Di Chiara G
    Neurol Sci; 2001 Feb; 22(1):63-4. PubMed ID: 11487203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of D2 agonists by striatal injection on excessive release of dopamine and hyperactivity induced by Bay K 8644 in rats.
    Maruya H; Watanabe Y; Okita M; Lawlor GF; Utsumi H; Niitsuma T
    Neuroscience; 2003; 118(4):1091-8. PubMed ID: 12732253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats.
    Koffarnus MN; Greedy B; Husbands SM; Grundt P; Newman AH; Woods JH
    Psychopharmacology (Berl); 2009 Apr; 203(2):317-27. PubMed ID: 18807248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does combined treatment with novel antidepressants and a dopamine D3 receptor agonist reproduce cocaine discrimination in rats?
    Filip M; Papla I
    Pol J Pharmacol; 2001; 53(6):577-85. PubMed ID: 11985331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists.
    Piercey MF; Hoffmann WE; Smith MW; Hyslop DK
    Eur J Pharmacol; 1996 Sep; 312(1):35-44. PubMed ID: 8891576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural effects of the dopamine D3 receptor agonist 7-OH-DPAT in rats.
    Ferrari F; Giuliani D
    Pharmacol Res; 1995; 32(1-2):63-8. PubMed ID: 8668649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44.
    Weber M; Chang WL; Durbin JP; Park PE; Luedtke RR; Mach RH; Swerdlow NR
    Pharmacol Biochem Behav; 2009 Aug; 93(2):141-7. PubMed ID: 19426754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
    Acri JB; Thompson AC; Shippenberg T
    Synapse; 2001 Mar; 39(4):343-50. PubMed ID: 11169785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine.
    Acquas E; Di Chiara G
    Eur J Pharmacol; 1999 Oct; 383(2):121-7. PubMed ID: 10585525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.